Article Correctness Is Author's Responsibility: A promising new treatment for recurrent pediatric brain cancer

The article below may contain offensive and/or incorrect content.

Administering medulloblastoma specific CAR T cells into the cerebrospinal fluid was more effective than administering via the blood.